The patents in contention are numbers 3,109,258, 2,222,710 and 3,178,490, all awarded by the European Patent Office and covering recombinant RSV antigens and compositions and methods for making them.

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...

Glaxo-Smith Kline, Hoechst Marion Roussel, Hoffman LaRoche, Janssen-Ortho, Oscient Pharmaceuticals, Merck Frosst, Pfizer, Rhone-Poulenc Rorer, Smith-Kline Beecham, Wyeth-Ayerst, YM Biosciences ...

Asthma has little, if any, significant effect on attained adult height. Untreated asthma results in a delay of puberty by approximately 1.3 years, and pubertal delay is likely to explain the majority ...